SciClone Takes Deeper Plunge In China Following Solid Q1 Results
This article was originally published in PharmAsia News
Executive Summary
SciClone sees more opportunities ahead as it plans deeper expansion into China, following Q1 results that posted a 38% increase in sales for its lead product.